Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025

Join our mailing lists

Sideline Scoop

Check out the upcoming week's schedule of local sports action, how to watch your favorite team, get highlights from recent games, and more.

Secure & Encrypted

What's your email address?

Who is this gift for?

Who is this gift from?

Delivery date

What's your billing location?

What's your delivery address?

Copy billing location

Subtotal:

Total:

How would you like to pay?

I Agree to the Subscription Terms of Use.

Secure transaction. Secure transaction. Cancel anytime.